
### [MONDO:0015078](http://purl.obolibrary.org/obo/MONDO_0015078)
**Label:** Gastroenteropancreatic endocrine tumor

**Subclasses:** [MONDO:0019955](http://purl.obolibrary.org/obo/MONDO_0019955) (GRFoma), [MONDO:0015069](http://purl.obolibrary.org/obo/MONDO_0015069) (neuroendocrine tumor of the anal canal), [MONDO:0018017](http://purl.obolibrary.org/obo/MONDO_0018017) (Goblet cell carcinoma), [MONDO:0019954](http://purl.obolibrary.org/obo/MONDO_0019954) (pancreatic neuroendocrine tumor), [MONDO:0019610](http://purl.obolibrary.org/obo/MONDO_0019610) (Zollinger-Ellison syndrome), [MONDO:0015065](http://purl.obolibrary.org/obo/MONDO_0015065) (ileal neuroendocrine tumor), [MONDO:0018016](http://purl.obolibrary.org/obo/MONDO_0018016) (classic neuroendocrine tumor of appendix), [MONDO:0015066](http://purl.obolibrary.org/obo/MONDO_0015066) (neuroendocrine tumor of the appendix), [MONDO:0019960](http://purl.obolibrary.org/obo/MONDO_0019960) (VIPoma), [MONDO:0015067](http://purl.obolibrary.org/obo/MONDO_0015067) (neuroendocrine tumor of the colon), [MONDO:0015068](http://purl.obolibrary.org/obo/MONDO_0015068) (neuroendocrine tumor of rectum), [MONDO:0015062](http://purl.obolibrary.org/obo/MONDO_0015062) (gastric neuroendocrine tumor), [MONDO:0015063](http://purl.obolibrary.org/obo/MONDO_0015063) (duodenal neuroendocrine tumor), [MONDO:0015064](http://purl.obolibrary.org/obo/MONDO_0015064) (jejunal neuroendocrine tumor), [MONDO:0006976](http://purl.obolibrary.org/obo/MONDO_0006976) (somatostatinoma), [MONDO:0006689](http://purl.obolibrary.org/obo/MONDO_0006689) (carcinoid syndrome), [MONDO:0005048](http://purl.obolibrary.org/obo/MONDO_0005048) (insulinoma (disease)), [MONDO:0019959](http://purl.obolibrary.org/obo/MONDO_0019959) (glucagonoma), [MONDO:0019957](http://purl.obolibrary.org/obo/MONDO_0019957) (PPoma), 

**Corr. equiv. classes:** [Orphanet:97283](http://www.orpha.net/ORDO/Orphanet_97283), [Orphanet:97261](http://www.orpha.net/ORDO/Orphanet_97261), [Orphanet:100078](http://www.orpha.net/ORDO/Orphanet_100078), [Orphanet:97282](http://www.orpha.net/ORDO/Orphanet_97282), [Orphanet:100079](http://www.orpha.net/ORDO/Orphanet_100079), [Orphanet:97280](http://www.orpha.net/ORDO/Orphanet_97280), [Orphanet:97253](http://www.orpha.net/ORDO/Orphanet_97253), [Orphanet:100075](http://www.orpha.net/ORDO/Orphanet_100075), [Orphanet:100076](http://www.orpha.net/ORDO/Orphanet_100076), [OMIM:114900](http://purl.obolibrary.org/obo/OMIM_114900), [Orphanet:100077](http://www.orpha.net/ORDO/Orphanet_100077), [Orphanet:329977](http://www.orpha.net/ORDO/Orphanet_329977), [Orphanet:329984](http://www.orpha.net/ORDO/Orphanet_329984), [Orphanet:100081](http://www.orpha.net/ORDO/Orphanet_100081), [Orphanet:97279](http://www.orpha.net/ORDO/Orphanet_97279), [Orphanet:100093](http://www.orpha.net/ORDO/Orphanet_100093), [Orphanet:100082](http://www.orpha.net/ORDO/Orphanet_100082), [Orphanet:913](http://www.orpha.net/ORDO/Orphanet_913), [Orphanet:97278](http://www.orpha.net/ORDO/Orphanet_97278), [Orphanet:100080](http://www.orpha.net/ORDO/Orphanet_100080), 

**Class expressions from DL-Learner:**

- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012334](http://purl.obolibrary.org/obo/HP_0012334) (Extrahepatic cholestasis) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0004297](http://purl.obolibrary.org/obo/HP_0004297) (Abnormality of the biliary system) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0002574](http://purl.obolibrary.org/obo/HP_0002574) (Episodic abdominal pain) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) 62.50%
- [HP:0012432](http://purl.obolibrary.org/obo/HP_0012432) (Chronic fatigue) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 62.50%


